Redman Rebecca - Univ Louisville | 人才画像

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 136 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract CT226: Phase 2 Study of Oral CCR4 Antagonist FLX475 (tivumecirnon) Plus Pembrolizumab in Subjects with Head and Neck Squamous Cell Carcinoma (HNSCC) Previously Treated with Checkpoint Inhibitor

Jameel Muzaffar,Kedar Kirtane,Rebecca Redman,Muh-Hwa Yang,Tae Min Kim,Stephen Liu,Ryan Lynch, Julie Brahmer,Patricia LoRusso,Brian Henick,Sung-bae Kim,Yin-Hsun Feng,Michael Chisamore,Paul Kassner,Dirk Brockstedt,Nicole Nasrah, Rakesh Goyal, William Y. Ho,Victoria Villaflor

Cancer Researchno. 7_Supplement (2024)

Cited0Views0Bibtex

Supplementary Table S11 from Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial

crossref（2024）

Cited0Views0Bibtex

Supplementary Figure S2 from Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial

crossref（2024）

Cited0Views0Bibtex

Supplementary Table S9 from Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial

crossref（2024）

Cited0Views0Bibtex

Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial

Clinical Cancer Researchpp.OF1-OF12, (2024)

Cited0Views0WOSBibtex

Supplementary Table S5 from Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial

crossref（2024）

Cited0Views0Bibtex

First-in-human, Dose Escalation and Expansion Study of MT-6402, a Novel Engineered Toxin Body (ETB) Targeting PD-L1, in Patients with PD-L1 Expressing Relapsed/refractory Advanced Solid Tumors: Interim Data

Brian A. Van Tine,Eugene Ahn,Rebecca A. Redman,Minal A. Barve,William J. Edenfield,Julio Peguero,Victoria M. Villaflor,Drew W. Rasco, Steven F. Powell,Admasu T. Mamuye,Chris B. Moore,Joshua M. Pelham, Soratree Charoenthongtrakul, David R. Spigel

CANCER RESEARCHno. 7 (2024)

Cited0Views0Bibtex

Supplementary Figure S1 from Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial

crossref（2024）

Cited0Views0Bibtex

Abstract CT191: First-in-human, Dose Escalation and Expansion Study of MT-6402, a Novel Engineered Toxin Body (ETB) Targeting PD-L1, in Patients with PD-L1 Expressing Relapsed/refractory Advanced Solid Tumors: Interim Data

Brian A. Van Tine,Eugene Ahn,Rebecca A. Redman,Minal A. Barve,William J. Edenfield,Julio Peguero,Victoria M. Villaflor,Drew W. Rasco,Steven F. Powell,Admasu T. Mamuye,Chris B. Moore,Joshua M. Pelham, Soratree Charoenthongtrakul, David R. Spigel

Cancer Researchno. 7_Supplement (2024)

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn